Genomic views of the immune system

被引:133
作者
Staudt, LM [1 ]
Brown, PO
机构
[1] NCI, Metab Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA
[2] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA
关键词
genomics; microarray; gene expression;
D O I
10.1146/annurev.immunol.18.1.829
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genomic-scale experimentation aims to view biological processes as a whole, yet with molecular precision. Using massively parallel DNA microarray technology, the mRNA expression of tens of thousands of genes can be measured simultaneously. Mathematical distillation of this flood of gene expression data reveals a deep molecular and biological logic underlying gene expression programs during cellular differentiation and activation. Genes that encode components of the same multi-subunit protein complex are often coordinately regulated. Coordinate regulation is also observed among genes whose products function in a common differentiation program or in the same physiological response pathway. Recent application of gene expression profiling to the immune system has shown that lymphocyte differentiation and activation are accompanied by changes of hundreds of genes in parallel. The databases of gene expression emerging from these studies of normal immune responses will be used to interpret the pathological changes in gene expression that accompany autoimmunity, immune deficiencies, and cancers of immune cells.
引用
收藏
页码:829 / 859
页数:37
相关论文
共 110 条
[51]   Positive versus negative signaling by lymphocyte antigen receptors [J].
Healy, JI ;
Goodnow, CC .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :645-670
[52]   Discovery and analysis of inflammatory disease-related genes using cDNA microarrays [J].
Heller, RA ;
Schena, M ;
Chai, A ;
Shalon, D ;
Bedilion, T ;
Gilmore, J ;
Woolley, DE ;
Davis, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2150-2155
[53]   14-3-3σ is a p53-regulated inhibitor of G2/M progression [J].
Hermeking, H ;
Lengauer, C ;
Polyak, K ;
He, TC ;
Zhang, L ;
Thiagalingam, S ;
Kinzler, KW ;
Vogelstein, B .
MOLECULAR CELL, 1997, 1 (01) :3-11
[54]   Dissecting the regulatory circuitry of a eukaryotic genome [J].
Holstege, FCP ;
Jennings, EG ;
Wyrick, JJ ;
Lee, TI ;
Hengartner, CJ ;
Green, MR ;
Golub, TR ;
Lander, ES ;
Young, RA .
CELL, 1998, 95 (05) :717-728
[55]   Mapping of a susceptibility locus for Crohn's disease on chromosome 16 [J].
Hugot, JP ;
LaurentPuig, P ;
GowerRousseau, C ;
Olson, JM ;
Lee, JC ;
Beaugerie, L ;
Naom, I ;
Dupas, JL ;
VanGossum, A ;
Orholm, M ;
BonaitiPellie, C ;
Weissenbach, J ;
Mathew, CG ;
LennardJones, JE ;
Cortot, A ;
Colombel, JF ;
Thomas, G .
NATURE, 1996, 379 (6568) :821-823
[56]   The transcriptional program in the response of human fibroblasts to serum [J].
Iyer, VR ;
Eisen, MB ;
Ross, DT ;
Schuler, G ;
Moore, T ;
Lee, JCF ;
Trent, JM ;
Staudt, LM ;
Hudson, J ;
Boguski, MS ;
Lashkari, D ;
Shalon, D ;
Botstein, D ;
Brown, PO .
SCIENCE, 1999, 283 (5398) :83-87
[57]   TUMOR NECROSIS FACTOR-ALPHA IN MURINE AUTOIMMUNE LUPUS NEPHRITIS [J].
JACOB, CO ;
MCDEVITT, HO .
NATURE, 1988, 331 (6154) :356-358
[58]   GENETIC DISSECTION OF AUTOIMMUNE TYPE-I DIABETES IN THE BB RAT [J].
JACOB, HJ ;
PETTERSSON, A ;
WILSON, D ;
MAO, Y ;
LERNMARK, A ;
LANDER, ES .
NATURE GENETICS, 1992, 2 (01) :56-60
[59]  
Jirholt J, 1998, EUR J IMMUNOL, V28, P3321, DOI 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO
[60]  
2-M